NP / PA
Schwartz, Sherry
Schwartz, Sherry was paid $19K by Medicaid between Sep 2019 and Jul 2020, across 6 billing codes. Its largest line is 87502, Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets — 35% of everything it billed.
33Billing provider infoSCHWARTZ, SHERRY
SEDALIA, MO 65301
SEDALIA, MO 65301
33aNPI1659544914assigned 04/08/2008
33bProvider typeFamily Nurse Practitioner
28Total paid$19K
24GClaims399
24DCodes billed6
24AFirst – last monthSep 2019 – Jul 2020
Compared with peers
Next to other Family Nurse Practitioner providers in Missouri
Rank by total paid#278 of 745
Median peer was paid$11K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 127 | $5K | |
| 2020 | 272 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 35% | 84 | 81 | $7K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 140 | 133 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 17% | 104 | 103 | $3K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 33 | 32 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.3% | 26 | 26 | $1K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.4% | 12 | 12 | $276.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.